Predictors of treatment outcomes in ANCA-associated vasculitis with severe kidney failure. - Wikidata - awgldk - TriplyDB

Predictors of treatment outcomes in ANCA-associated vasculitis with severe kidney failure.

Predictors of treatment outcomes in ANCA-associated vasculitis with severe kidney failure.

http://www.wikidata.org/entity/Q33571802

about

The Prevalence and Management of Pauci-Immune Glomerulonephritis and Vasculitis in Western Countries Antithyroid drug-associated MPO-ANCA-positive tubulointerstitial nephritis in a type 2 diabetes patient: a case report.Improved prognosis in Norwegian patients with glomerulonephritis associated with anti-neutrophil cytoplasmic antibodies.Older patients with ANCA-associated vasculitis and dialysis dependent renal failure: a retrospective study.ANCA positive crescentic glomerulonephritis outcome in a Central East European cohort: a retrospective study.Predictors of relapses in ANCA-associated small vessel vasculitis with kidney involvement.Renal transplantation in anti-neutrophil cytoplasmic antibody-associated vasculitis.Long-term outcomes for primary glomerulonephritis: New Zealand Glomerulonephritis Study.Conventional induction and maintenance treatment of Antineutrophil cytoplasmic antibodies-associated vasculitis - still of value for our patients?Renal vasculitis presenting with acute kidney injury.Pneumo-Renal Syndrome in Anti- Neutrophil Cytoplasm Antibody (ANCA)-Associated Small-Vessel Vasculitis Pauci-immune glomerulonephritis: does negativity of anti-neutrophilic cytoplasmic antibodies matters?Clinical characteristics of inflammatory ocular disease in anti-neutrophil cytoplasmic antibody associated vasculitis: a retrospective cohort study.The Diagnosing Challenge of a Positive ANCA Vasculitis in the Paediatric Age.Patient Outcomes in Renal-Limited Antineutrophil Cytoplasmic Antibody Vasculitis With Inactive Histology.Costs of Disease Relapses Among Individuals with Granulomatosis, with Polyangiitis, or Microscopic Polyangiitis in the United States.Histopathological Classification-A Prognostic Tool for Rapidly Progressive Glomerulonephritis Prognostic Factors for Survival and Relapse in ANCA-Associated Vasculitis with Renal Involvement: A Clinical Long-Term Follow-Up Study Pediatric Nephrology and Rheumatology Practice Patterns in Granulomatosis with Polyangiitis: A Midwest Pediatric Nephrology Consortium Study

P2860

Q26740451-55499C38-DC1F-477C-A582-74D3749281A1 Q33710246-298630AA-8DA9-4A72-836D-16B2ED99DF6A Q35212086-B65A5F54-227C-4A2D-953C-B8EFE892AD95 Q35673484-9A3667D0-5CAF-4663-B6C4-83FFDA56B12A Q35678050-37FABA22-11EE-4D19-B169-3F884B4568FA Q36744892-4AE26E01-8D1C-4391-9A8A-190DF2555437 Q38260987-7C9369FF-F30E-4EB8-AAE7-1EEF2DCF9AE7 Q38533858-7B76D2D7-B6EB-47E1-9761-4DCEA0204373 Q38543360-6F4135E4-5FCF-4025-969D-B4868DF705D5 Q40295571-1CDF0058-BE19-455B-8CC3-4DD8580549C2 Q42319739-C928114F-22C9-4C2E-80B7-8B6BF38ABF96 Q45917648-32E290EF-887B-4FF7-8EF3-A686DE5D0A13 Q47626112-E90CCBCB-16C0-46BD-AE70-67CDACC8A116 Q48093905-4305DB78-F5A8-47BA-8903-134DE821293D Q54966495-B352293A-AF7A-495A-BC48-6C1243D3D945 Q55234250-28F9019C-F31E-4653-B68F-799EE6384796 Q57825808-5B7EBABF-E52F-48B1-92FA-A4C88606A7CD Q58555878-DB186F3C-C7C9-4B07-B7FE-C5D92EE4068A Q58800147-CDE18ED8-DFE5-4320-AB48-48A1C525EA18

P2860

Predictors of treatment outcomes in ANCA-associated vasculitis with severe kidney failure.

http://www.wikidata.org/entity/Q33571802

description

2014 nî lūn-bûn

@nan

2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Predictors of treatment outcom ...... is with severe kidney failure.

@ast

Predictors of treatment outcom ...... is with severe kidney failure.

@en

Predictors of treatment outcom ...... is with severe kidney failure.

@nl

type

label

Predictors of treatment outcom ...... is with severe kidney failure.

@ast

Predictors of treatment outcom ...... is with severe kidney failure.

@en

Predictors of treatment outcom ...... is with severe kidney failure.

@nl

prefLabel

Predictors of treatment outcom ...... is with severe kidney failure.

@ast

Predictors of treatment outcom ...... is with severe kidney failure.

@en

Predictors of treatment outcom ...... is with severe kidney failure.

@nl

P1433

Q33571802-73DEA4BE-61B1-4EE4-9412-FEE51B63BE3E

P1476

Q33571802-31CC8BB2-3592-4902-A22F-94B2CE73A4EB

P2093

Q33571802-1D860DD8-2FB7-4B3D-A85A-CC6BC2C28623

Q33571802-3B9FC02E-049A-4C28-AA7E-1BDEF215376C

Q33571802-4F8EBD9B-4383-415F-80D7-046C961A4775

Q33571802-7BA16264-F813-40FC-AB49-FD942CEF2733

Q33571802-8213B587-E547-48A1-A70B-B748A3A523F2

Q33571802-9BFAD990-D9AB-4A0C-B1A7-93E189FFBDE0

Q33571802-C16736A1-590B-4295-B747-12E282FA00D0

Q33571802-CB08ED9F-4197-4B5C-A3C6-0A6B0ADB03C0

Q33571802-DC73C4AC-F299-46C9-A600-B9D0EF83ECCA

P2860

Q33571802-00A5A72B-2BDF-42C5-A1FB-2BB05E095AD3

Q33571802-14231E3B-38B1-4747-A5A4-D62394072830

Q33571802-147E1042-4C0C-4EE1-BF1A-4955DF1DAB7B

Q33571802-1C4E6760-1F28-429E-88C0-CE175261263D

Q33571802-3FF91FE1-9377-48DC-8C83-58196AEBDAB6

Q33571802-45B617F3-FA11-4E3C-9177-66D9318F203C

Q33571802-7A1255BC-EA8A-45DA-B012-357A94D70FA8

Q33571802-8D2DF0E7-71FF-4FF7-9C5D-87E6A4E91B8B

Q33571802-922EAE56-EE78-4AE3-BC7C-F7ED8711ED15

Q33571802-9B767526-B641-48BA-9F16-FBCA894991E8

P304

Q33571802-94B4E484-AECB-4AD9-B2BE-05EC13DFEC27

P31

Q33571802-8B05A567-D3DB-4B4A-8471-77E6C1388691

P356

Q33571802-6B4C7E28-F9C3-46D4-A71F-0310D958952A

P433

Q33571802-CBFC9766-534A-4DCA-B40E-D66EAA5A4ACD

P478

Q33571802-24882200-62F8-4E72-9B32-55B95C88304B

P50

Q33571802-3C6D66F3-7B8E-4CCC-9191-C0AEC2512A05

Q33571802-B7B807C9-7D8C-4472-94E7-6A9D62A3B059

P577

Q33571802-3BAAAE56-C012-4F90-9CB5-0F5A047ADEE5

P698

Q33571802-FE2D3F29-128C-486E-B4BA-A0A5BA08B28F

P932

Q33571802-6C28DD77-ACAC-4E86-9BDB-981E9CDCD925

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

Predictors of treatment outcom ...... is with severe kidney failure.

@en

P2093

Adil Gasim

http://www.w3.org/2001/XMLSchema#string

Caroline J Poulton

http://www.w3.org/2001/XMLSchema#string

J Charles Jennette

http://www.w3.org/2001/XMLSchema#string

JulieAnne G McGregor

http://www.w3.org/2001/XMLSchema#string

Patrick H Nachman

http://www.w3.org/2001/XMLSchema#string

Ronald J Falk

http://www.w3.org/2001/XMLSchema#string

Susan L Hogan

http://www.w3.org/2001/XMLSchema#string

Taewoo Lee

http://www.w3.org/2001/XMLSchema#string

Yunro Chung

http://www.w3.org/2001/XMLSchema#string

P2860

Incidence and outcome of pauci-immune rapidly progressive glomerulonephritis in Wessex, UK: a 10-year retrospective study

2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

Cumulative incidence in competing risks data and competing risks regression analysis.

Prediction of ESRD in pauci-immune necrotizing glomerulonephritis: quantitative histomorphometric assessment and serum creatinine

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate.

Histopathologic classification of ANCA-associated glomerulonephritis.

Rituximab versus cyclophosphamide for ANCA-associated vasculitis.

A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis

EULAR recommendations for the management of primary small and medium vessel vasculitis.

The clinical course of ANCA small-vessel vasculitis on chronic dialysis.

P304

905-913

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.08290813

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Vimal K. Derebail

P577

2014-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24578329

http://www.w3.org/2001/XMLSchema#string

P932

4011446

http://www.w3.org/2001/XMLSchema#string